NCT06767397

Brief Summary

Patients are at risk for hemodynamic instability both during and after surgery, as it is an independent predictor of long-term patient morbidity and length of hospital stay. The development of hemodynamic instability is caused by a number of factors. When these risk factors are prevented or treated, patients may experience less hemodynamic instability during pelvic surgery, as well as the morbidity and mortality that come with it in both spinal and general anesthesia.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
172

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 9, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

January 9, 2025

Status Verified

January 1, 2025

Enrollment Period

5 months

First QC Date

December 18, 2024

Last Update Submit

January 5, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Hemodynamic instability

    Hemodynamic instability determined by criteria such as fluctuations of ± 20% in the systolic or diastolic blood pressure from the baseline and measured in millimetre of mercury), fluctuations in heart rate (e.g., pulse rate ± 10% of baseline), and the lack of clinically significant hypotension or episodes of bradycardia.Oxygen saturation measured by pulse oximeter and \< 90% of SPO2 was considered desaturated.

    12 Months

  • Self-designed questionnaire

    Self-designed questionnaire for the evaluation of the factors like Age in years, weight in kilograms, Physical health status by (ASA) American Society of Anesthesiologists classification where ASA I was physically fit patients having only surgical pathology and ASA II patient with mild systemic disease. scoring from (1-100)

    12 Months

Interventions

general anesthesiaDIAGNOSTIC_TEST

To evaluate the factors that affect the hemodynamic stability in patients undergoing spinal anesthesia and general anesthesia during pelvic surgery.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Intraoperatively hemodunamic instability during spinal and general anesthesia was adressed and also evaluate its management.

You may qualify if:

  • Adult patients aged 18 years and older.
  • ASA (American Society of Anesthesiologists) physical status classification I and II.
  • Patients scheduled for elective pelvic surgery.
  • Can give informed consent or has a legal representative to give consent.
  • There are no contraindications to spinal or general anesthesia based on preoperative assessment (e.g, severe cardiovascular disease, no previous history of adverse anesthetic reactions).

You may not qualify if:

  • Age below 18 years.
  • Emergency procedures or that require immediate intervention.
  • Pregnancy or breastfeeding status.
  • Conditions such as spinal cord disease and severe coagulopathy that are recognized contraindications to spinal or general anesthesia.
  • ASA physical status classification III and above.
  • History of severe adverse reactions to anesthesia or known allergy to anesthetic agents.
  • Concurrent involvement in additional clinical trials that could have an impact on the treatment of anesthesia or hemodynamic results.
  • Individuals with substantial comorbidities (such as uncontrolled hypertension or heart failure) that might complicate hemodynamic responses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mardan Medical Complex

Mardan, Khyber Pakhtunkhwa, Pakistan

Location

MeSH Terms

Conditions

Pelvic Floor Disorders

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 18, 2024

First Posted

January 9, 2025

Study Start

February 28, 2024

Primary Completion

August 1, 2024

Study Completion

March 1, 2025

Last Updated

January 9, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations